Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OmniSYS is a U.S. healthcare technology company focused on software and services for retail, specialty, and health-system pharmacy operations rather than drug development. The company built solutions for Medicare Part B and medical billing, revenue cycle management, clinical documentation, workflow enablement, and patient engagement for pharmacies and related healthcare stakeholders. OmniSYS was acquired by XiFin in December 2021 and its offerings were later rebranded under the XiFin Pharmacy Solutions name in August 2024. The business serves large U.S. pharmacy customers and supports pharmacies as they expand clinical services such as testing, vaccinations, medication therapy management, and diabetes education. For a biotech analyst, this is best understood as a commercial healthtech/pharmacy software asset, not a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OmniSYS.